Good morning, everyone. A spot of snow is falling on the Pharmalot corporate campus today. So much for spring. Nonetheless, we persevere thanks, in part, to a cup of stimulation - our flavor today is Southern Pecan. Meanwhile, we are gearing up for those meetings and deadlines, and trust you are doing the same. To help you along, here are some tidbits from around the world. Hope you have a productive day and catch you soon...
Novartis Must Wait Longer For FDA Decision On COPD Drug (Reuters)
Glaxo Scraps Plan To Market Prostate Cancer Med (Associated Press)
Former Pfizer CEO And His Severance (Associated Press)
Medicare Ordered To Pay For Off-Label Drugs (American Medical News)
Bristol Pays CEO Andreotti $11M In Compensation (Associated Press)
Gilead HIV Drug Meets Main Trial Goal (Reuters)
Pfizer Reaches Deal To End Quigley Unit Bankruptcy (Bloomberg News)
Sanofi Raising $7B To Fund Genzyme Deal (New York Times)
Quintiles Delays Borrowing Plans (Raleigh News & Observer)
Abbott And Seattle Genetics Strike Deal (GenEn News)
EDITOR'S NOTE: Please check back for updates throughout the morning